AEON Biopharma
AEON
AEON
73 hedge funds and large institutions have $205M invested in AEON Biopharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.05% more ownership
Funds ownership: 1.04% → 1.09% (+0.05%)
Holders
73
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$5.13M | |
| 2 | +$2.91M | |
| 3 | +$2.45M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.29M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$1.61M |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$4.89M | |
| 3 | -$1.22M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.01M |
| 5 |
AR
Advisory Research
Chicago,
Illinois
|
-$993K |